Acadia Healthcare Company, Inc.

Análisis de la acción Acadia Healthcare Company, Inc. (ACHC)

$31.670

+1.507 (+4.76%)Al cierre

Loading chart…
Máximo
31.895
Apertura
30.010
Precio medio ponderado por volumen
31.19
Volumen
1.81M
Capitalización
6.31B
Mínimo
30.010
Importe
56.50M
EV/EBITDA, TTM
9.23

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting.

Análisis de IA of Acadia Healthcare Company, Inc. (ACHC)

Comprar

Acadia Healthcare Company Inc (ACHC) appears to be a good buy right now due to its current price of $29.25, which is below the analyst price target of $39, indicating significant upside potential. Additionally, the company has shown a strong year-to-date change of +104.69%, reflecting robust performance. However, a key risk is the negative sentiment from hedge funds, which have increased selling by 194.77% over the last quarter.

Recomendaciones de analistas (17)

-42.85% Potencial de caída
Comprar
10 Comprar
7 Mantener
0 Vender
Actual: 31.67
Mínimo
13.00
Promedio
18.10
Máximo
25.00

Raymond James

2026-09-28

Precio objetivo

$39

Superar al mercado

Leerink

2026-09-23

Precio objetivo

$33

Market Perform

Guggenheim

2026-07-30

Precio objetivo

$39

Comprar

Barclays

2026-07-30

Precio objetivo

$32

Equal Weight

BofA

2026-07-29

Precio objetivo

$13

Inferior al mercado

Métricas de valoración

El PER previsto actual de Acadia Healthcare Company, Inc. (ACHC) es 15.24, frente a su media de 5 años de 17.92.

PER previsto

Valor razonable
Media 5A P/E
17.92
P/E actual
15.24
Sobrevalorada
23.58
Infravalorada
12.25

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
9.80
EV/EBITDA actual
9.23
Sobrevalorada
13.96
Infravalorada
5.63

Precio/ventas previsto

Infravalorado
Media 5A P/S
1.67
P/S actual
0.78
Sobrevalorada
2.47
Infravalorada
0.86

Escenarios de precio de Alphio AI para ACHC

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%ACHC

$29.90

Precio del escenario

B

Base

Base · 50%ACHC

$25.39

Precio del escenario

B

Bajista

Bajista · 25%ACHC

$23.05

Precio del escenario

Ballenas con ACHC en cartera

B

Braidwell LP

+ Con en carteraACHC

+16.13%

Rentabilidad a 3 meses

A

Abrams Bison Investments, L.L.C.

+ Con en carteraACHC

+1.48%

Rentabilidad a 3 meses

G

Greenlight Capital, Inc.

+ Con en carteraACHC

-7.28%

Rentabilidad a 3 meses

D

Deerfield Management Company, L.P.

+ Con en carteraACHC

-7.98%

Rentabilidad a 3 meses

Preguntas frecuentes sobre ACHC, respondidas por Alphio AI

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates in the Healthcare sector (SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC industry).

Acadia Healthcare Company Inc (ACHC) appears to be a good buy right now due to its current price of $29.25, which is below the analyst price target of $39, indicating significant upside potential. Additionally, the company has shown a strong year-to-date change of +104.69%, reflecting robust performance. However, a key risk is the negative sentiment from hedge funds, which have increased selling by 194.77% over the last quarter.

17 analysts cover ACHC: 10 rate it Buy, 7 Hold and 0 Sell. The average price target is 18.10.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar